Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound oral thrombolytic preparation and its preparing method

A technology of compound Xueshuantong and its raw materials, which is applied in the preparation of the drug, in the field of compound Xueshuantong oral preparations, can solve the problems of weak effect and increased patient compliance, achieve safe use, improve blood rheology, and have no bitterness Effect

Inactive Publication Date: 2003-06-25
GUANGDONG ZHONGSHENG PHARMA
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, total ginsenosides have weak effects on these systems
In addition, since Xueshuantong injection needs to be administered intravenously, long-term treatment will bring additional pain to the patient, and if it is changed to oral administration, the patient's compliance will increase

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0062] Weigh raw materials according to the following ratio (grams)

[0063] Notoginseng 250 Astragalus 80 Salvia 50 Scrophulariae 80

[0064] The first kind of production method that above-mentioned each component is made medicine of the present invention is:

[0065] Grind Panax notoginseng into coarse powder, immerse in 50% ethanol for ultrasonic extraction twice, the first time is 28 hours, the second time is 5 hours, filter, combine the filtrate, recover ethanol, concentrate into a thick paste; the rest of Astragalus and other three herbs Heat and reflux twice with 50% ethanol, the first time for 3 hours, the second time for 2 hours, filter, combine the filtrate, recover the ethanol, and concentrate to a relative density of 1.2 to 1.35; the above two kinds of extracts are mixed according to the ratio of the feeding amount , Add polyethylene glycol (the ratio of extract: polyethylene glycol is 1:0.8~6.0). When heating and dissolving until the liquid temperature is 80°C t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The compound orally taken thrombolytic preparation is used in treating retina venous blocking, vascular retina patholgoic change, coronary heart disease and angina pectoris. It is prepared with notoginseng, astragalus root, red sage and figwort as material and prepared in the forms of drip pills, granule, table, capsule or oral mixture liquid. The present invention has unique recipe and preparation process and obvious curative effect.

Description

technical field [0001] The invention relates to a medicine for treating retinal vein occlusion, central serous chorioretinopathy and coronary heart disease angina pectoris made from plant Chinese herbal medicine, especially compound Xueshuantong oral preparation. The invention also relates to the preparation method of the medicine , named after various preparations prepared by the present invention as Compound Xueshuantong plus the name of the dosage form. Background technique [0002] This product is used for the treatment of violent blindness (retinal vein occlusion), central serous chorioretinopathy and coronary heart disease angina pectoris caused by blood stasis and deficiency of both qi and yin. The drugs closest to the treatment indications of this product are Xueshuantong Injection, Xuesaitong Tablets, and Xuesaitong Preparations. The active ingredient of this kind of medicine is total ginsenoside, which is the main component of Panax notoginseng, which has the func...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P7/02A61P9/10A61P27/02
Inventor 胡兆科
Owner GUANGDONG ZHONGSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com